Clobenpropit dihydrobromide, VUF 9153 has been shown to be an extremely potent (pA2 = 9.93) and selective histamine H3 receptor antagonist. This compound has been found to enhance the release of GABA, which protects against NMDA-induced exitotoxicity. Further experiments suggest that clobenpropit dihydrobromide my inhibit the binding of iodophenpropit, and therefor may possess the ability to cross the blood-brain barrier.
1. Yokoyama, H., et al. 1994. Eur. J. Pharmacol. 260: 23-28. PMID: 7957622
2. Harada, C., et al. 2004. Brain Res. Bull. 63: 143-146. PMID: 15130703
3. Dai, H., et al. 2007. Eur. J. Pharmacol. 563: 117-123. PMID: 17350613
4. Devi, P.U., et al. 2010. Hum Exp Toxicol. [Epub ahead of print]. PMID: 20511290
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.